Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	184	156	72	169	276	200
Market Cap Growth	92.63%	117.39%	-57.49%	-38.80%	38.33%	-49.05%
Enterprise Value	200	134	47	95	151	98
Last Close Price	1.91	2.36	1.67	3.96	6.55	6.70
PS Ratio	-	-	71.91	33.83	18.43	-
PB Ratio	-	11.89	4.29	2.55	2.46	1.40
P/TBV Ratio	-	11.89	4.29	2.55	2.46	1.40
EV/Sales Ratio	-	-	47.19	18.90	10.05	-
Debt / Equity Ratio	-3.18	4.17	3.09	0.04	0.01	0.01
Asset Turnover	-	-	0.01	0.05	0.11	-
Quick Ratio	4.82	8.79	9.34	10.72	16.92	23.26
Current Ratio	4.97	9.10	10.11	11.70	17.55	24.14
Return on Equity (ROE)	-780.29%	-277.55%	-143.61%	-65.26%	-33.52%	-38.73%
Return on Assets (ROA)	-50.33%	-34.92%	-51.01%	-38.36%	-19.95%	-23.18%
Return on Capital (ROIC)	-55.52%	-38.56%	-55.59%	-40.93%	-20.92%	-24.43%
Earnings Yield	-29.69%	-26.56%	-83.00%	-34.52%	-15.50%	-25.01%
FCF Yield	-21.62%	-18.48%	-64.72%	-31.18%	-12.02%	-25.39%
Buyback Yield / Dilution	-31.05%	-44.82%	-1.19%	-1.47%	-42.56%	-85.91%

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q